The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Belova L.A.

Ul'ianovskiĭ gosudarstvennyĭ universitet

Mashin V.V.

Proshin A.N.

Ulyanovsk State University, Ulyanovsk

Ovsjannikova A.N.

Ulyanovsk State University, Ulyanovsk, Russia

Kostishko B.B.

Ulyanovsk State University, Ulyanovsk

Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke

Authors:

Belova L.A., Mashin V.V., Proshin A.N., Ovsjannikova A.N., Kostishko B.B.

More about the authors

Read: 3427 times


To cite this article:

Belova LA, Mashin VV, Proshin AN, Ovsjannikova AN, Kostishko BB. Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(9):51‑58. (In Russ.)
https://doi.org/10.17116/jnevro20171179151-58

Recommended articles:
Clinical and gene­tic asso­ciations in patients with non-cardioembolic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):12-19
Biomarkers of athe­rothrombotic and cardioembolic subtypes of acute ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):20-26
Clinical and tomo­graphic comparisons in patients with apha­sia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):27-33
Neuroimaging predictors of hemo­rrhagic transformation of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):34-38
Neurocytoprotection adva­nces in repe­rfusion therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):75-88
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
Central nervous system invo­lvement in systemic lupus erythematosus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):124-129
Neuroprotective therapy of glaucoma. Russian Annals of Ophthalmology. 2025;(1):83-90

References:

  1. Skvortsova VI. Formation of system of rendering of medical aid to patients with cerebral stroke in the Russian Federation. Mat. Vseros. scientific.-pract. Conf. «Improvement of rendering of medical aid to patients with vascular diseases». M.: Real Time; 2011. (In Russ.).
  2. Belova LA, Mashin VV. Venous Discirculation in Chronic Forms of Cerebrovascular Pathology. M.: LLC All Print; 2016.
  3. Thrift AG, Thayabaranathan T, Howard G, Howard VJ, Rothwell PM, Feigin VL, Norrving B, Donnan GA, Cadilhac DA. Global stroke statistics. Int J Stroke. 2017;12(1):13-32. https://doi.org/10.1177/1747493016676285
  4. Belova LA, Mashin VV, Saprygina LV, Kravchenko MA, Gnedovskaya EV, Oschepkova EV, Varakin YuYa, Suslina ZA. Structure of cerebrovascular disease in an open population the working population of Ulyanovsk. Annals of clinical and experimental neurology. 2014;4(8):4-8. (In Russ.).
  5. Mashin V, Belova L, Moiseyev M, Achmetova R, Kazimova E, Urdina A. Clinical-neurological and neuroimaging of diagnosis of venous stroke. International Angiology. 2016;35(2):94.
  6. Reis C, Akyol O, Ho WM, Araujo C, Huang L, Applegate RII, Zhang JH. Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research. Biomed Res Int. 2017;4863079. https://doi.org/10.1155/2017/4863079
  7. Khoshnam SE, Winlow W, Farzaneh M, Farbood Y, Moghaddam HF. Pathogenic mechanisms following ischemic stroke. Neurological Scienses. 2017;38(7):1167-1186. https://doi.org/10.1007/s10072-017-2938-1
  8. Song SH, Kim JH, Lee JH, Yun Y-M, Choi D-H, Kim HY. Elevated blood viscosity is associated with cerebral small vessel disease in patients with acute ischemic stroke. BMC Neurology. 2017;17:20. https://doi.org/10.1186/s12883-017-0808-3
  9. Alkuraishy HM, Al-Gareeb AI, Albuhadilly AK. Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders — a randomized controlled clinical study. Biomed Res Int. 2014;324307. https://doi.org/10.1155/2014/324307
  10. Nivison-Smith L, Khoo P, Acosta ML, Kalloniatis M. Pre-treatment with vinpocetine protects against retinal ischemia. Exp Eye Res. 2017;154:126-138. https://doi.org/10.1016/j.exer.2016.11.018
  11. Zhang L, Yang L. Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature. Molecules. 2014;20(1):335-347. https://doi.org/10.3390/molecules20010335.Review
  12. Suslina ZA, Tanashyan MM, Ionova VG, Kistenev BA, Maksimova MYu, Sharypov TN. Cavinton in the treatment of patients with ischemic disorders of cerebral circulation. RMG. 2002;25:1170-1174. (In Russ.).
  13. Живолупов С.А., Самарцев И.Н., Яковлев Е.В., Бутакова Ю.С., Бодрова Т.В. Оценка эффективности винпоцетина (Кавинтона Комфорте) в лечении головокружения у пациентов с дисциркуляторной энцефалопатией по уровню нейротрофического фактора мозга (BDNF) в плазме крови. Клиническая фармакология и терапия. 2016;25(1):2-7. [Zhivolupov SA, Samartsev IN, Yakovlev EV, Butakov YS, Bodrova TV. Evaluation of the effectiveness of Vinpocetine (Cavinton Comfort) in the treatment of vertigo in patients with dyscirculatory encephalopathy on the level of neurotrophic factor brain (BDNF) in blood plasma. Clinical pharmacology and therapy. 2016;25(1):2-7.
  14. Chukanova EI. Current aspects of the epidemiology and treatment of chronic brain ischemiain the presence of essential hypertension (results of the CALIPSO program). Neurology, Neuropsychiatry, Psychosomatics. 2011;3(1):38-42. (In Russ.). https://doi.org/10.14412/2074-2711-2011-132
  15. Tanashyan MV, Lagoda OV, Antonov KV, Konovalov RN. Chronic cerebrovascular diseases and metabolic syndrome: approaches to pathogenetic therapy of cognitive disorders. Journal of neurology and psychiatry im. S.S. Korsakov. 2016;116(9):98-102. (In Russ.).
  16. Tabeeva GR, Azimova YuE. A multimodal strategy of neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program of SOKOL (Assessment of Comparative effectiveness Cavinton and Conventional schemes of treatment of patients with acute violation of cerebral circulation). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(12):20-30. (In Russ.).
  17. Zhang W, Huang Y, Li Y, Tan L, Nao J, Hu H, Zhang J, Li C, Kong Y, Song Y. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology). Trial Clin Drug Investig. 2016;36(9):697-704. https://doi.org/10.1007/s40261-016-0415-x
  18. Hertz H. Überdie Berührung fester elastischer Körper. Journal für die reine und angewandte Mathematik. 1881;92:156-171.
  19. Catanese L, Tarsia J, Fisher M. Acute Ischemic Stroke Therapy Overview. Circ Res. 2017;120(3):541-558. https://doi.org/10.1161/CIRCRESAHA.116.309278

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.